Robert C. Getts
Directeur/Bestuurslid bij Genisphere LLC
Profiel
Robert C.
Getts is currently a Director at Genisphere LLC.
Previously, he worked as a Principal at Philadelphia College of Osteopathic Medicine.
He holds a doctorate degree from Lehigh University and undergraduate and graduate degrees from the University of Scranton.
Actieve functies van Robert C. Getts
| Bedrijven | Functie | Begin |
|---|---|---|
Genisphere LLC
 Genisphere LLC Electronic Equipment/InstrumentsElectronic Technology Genisphere LLC manufactures kits and reagents used for the ultra-sensitive detection of nucleic acids and proteins. Its solutions are primarily based on its proprietary whole transcriptome RNA Amplification processes, miRNA labeling methodologies, and 3DNA Dendrimer Nanotechnology. The firm's combined technologies permit the interrogation and ultra-sensitive detection of a wide range of biomolecules on a variety of detection platforms, including microarrays, flow and bead based assays, ELISAs, lateral flow assays and RNA sequencing. The company was founded in 1997 and is headquartered in Hatfield, PA. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Robert C. Getts
| Bedrijven | Functie | Einde |
|---|---|---|
| Philadelphia College of Osteopathic Medicine | Corporate Officer/Principal | - |
Opleiding van Robert C. Getts
| University of Scranton | Graduate Degree |
| Lehigh University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Genisphere LLC
Genisphere LLC Electronic Equipment/InstrumentsElectronic Technology Genisphere LLC manufactures kits and reagents used for the ultra-sensitive detection of nucleic acids and proteins. Its solutions are primarily based on its proprietary whole transcriptome RNA Amplification processes, miRNA labeling methodologies, and 3DNA Dendrimer Nanotechnology. The firm's combined technologies permit the interrogation and ultra-sensitive detection of a wide range of biomolecules on a variety of detection platforms, including microarrays, flow and bead based assays, ELISAs, lateral flow assays and RNA sequencing. The company was founded in 1997 and is headquartered in Hatfield, PA. | Electronic Technology |
